The Role of Push Enteroscopy in Patients With Passing Melena With Nondiagnostic EGD.

Melena is generally attributed to bleeding from the upper gastrointestinal (GI) tract, with esophagogastroduodenoscopy (EGD) serving as the primary diagnostic tool. However, EGD fails to detect bleeding sources in approximately 25% of cases, necessitating further investigation into potential mid-to-lower GI bleeding. Current guidelines recommend performing a colonoscopy in patients with melena and a negative EGD result before exploring small bowel sources. The effectiveness of colonoscopy in identifying bleeding sources varies significantly, with large-scale studies indicating a low detection rate of around 4.76%, while smaller studies report higher rates, ranging from 23% to 35%.

Despite thorough evaluations using both EGD and colonoscopy, the cause of overt GI bleeding remains unidentified in 4% to 15% of cases, prompting consideration of small bowel bleeding. Video capsule endoscopy (VCE) is often recommended in this situation due to its high diagnostic yield and noninvasive nature. However, VCE has limitations, such as missing proximal small bowel lesions and the inability to provide therapeutic interventions.

Push enteroscopy (PE) offers an alternative approach for investigating obscure GI bleeding. This straightforward endoscopic technique, which most gastroenterologists can perform without specialized equipment, is cost-effective and diagnostically efficient, with yields ranging from 30% to 50%. Utilizing PE in patients with melena and a negative EGD may help avoid unnecessary procedures like colonoscopy and VCE, ultimately reducing treatment costs.

This study aims to compare the diagnostic effectiveness of push enteroscopy (PE) and colonoscopy in patients presenting with melena, no hematemesis, and negative EGD results.

Inclusion criteria

• Patients aged 18 years or older.
• Patients admitted to the hospital for acute gastrointestinal bleeding, presenting with symptoms of melena.
• Patients who have undergone esophagogastroduodenoscopy (EGD) without identification of the source of gastrointestinal bleeding.
• Patients who have signed informed consent to participate in the study.

Exclusion criteria

• Patients with symptoms of hematemesis, coffee ground emesis, or detection of blood via a gastric lavage tube.
• Patients with unstable vital signs before undergoing push enteroscopy.
• Patients with conditions that contraindicate endoscopy, such as severe asthma or serious cardiac conditions.
• Patients with a history of bleeding disorders or uncorrectable coagulation abnormalities.
• Patients who have contraindications to bowel preparation with polyethylene glycol.
• Pregnant patients.